Published in AIDS Weekly, July 3rd, 2000
This is the subject of the fourth in a series of six articles published by The Lancet in the build-up to the World AIDS 2000 Conference in Durban, South Africa, July 9-14.
Patients' activist Mark Harrington and clinician Charles Carpenter discuss data that justify a balanced approach and the feasibility of randomized controlled trials to provide clearer answers about when to start HIV drug treatment.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.